Evidence map›Paper›PMID 26380985›Full record

ArticleDiabetologia2015

Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study.

Mark D DeBoer, Matthew J Gurka, Jessica G Woo, John A Morrison

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome.The Journal of clinical endocrinology and metabolism · 2025
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Mark D DeBoerDivision of Pediatric Endocrinology, University of Virginia, P.O. Box 800386, Charlottesville, VA, 22908, USA. deboer@virginia.edu.
Matthew J GurkaDepartment of Biostatistics, School of Public Health, West Virginia University, Morgantown, WV, USA.
Jessica G WooDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
John A MorrisonDivision of Cardiology, University of Cincinnati, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USUniversity of Virginia · USWest Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$81.0M
West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI DEVRIES, ANNE COURTNEY · 2014 to 2024
$24.5M
Socioeconomic Status and Subjective Social Status as Modifiers of Stressors and Discrimination in their Relationship with MetS Severity Over TimeR01HL120960 · NHLBI · WEST VIRGINIA UNIVERSITY · PI DEBOER, MARK DANIEL, GURKA, MATTHEW JAMES · 2014 to 2018
$2.1M
Inflammatory Mechanisms of Puberty Dysregulation in ColitisK08HD060739 · NICHD · UNIVERSITY OF VIRGINIA · PI DEBOER, MARK DANIEL · 2009 to 2013
$649k
Development of a childhood metabolic syndrome risk score for predicting adult disR21DK085363 · NIDDK · WEST VIRGINIA UNIVERSITY · PI DEBOER, MARK DANIEL, GURKA, MATTHEW JAMES · 2010 to 2011
$231k
SUPPORT FOR LIPID RESEARCH CLINICN01HV022914 · HV · UNIVERSITY OF CINCINNATI · PI SPRECHER, DENNIS L · 1985 to 1990
–
NHLBI NIH HHS 1R01HL120960NHLBI NIH HHS NHLBI N01HV22914NHLBI NIH HHS R01 HL120960NICHD NIH HHS K08 HD060739NICHD NIH HHS K08HD060739NIDDK NIH HHS 1R21DK085363NIDDK NIH HHS R21 DK085363NIGMS NIH HHS P20 GM109098NIGMS NIH HHS U54 GM104942NIGMS NIH HHS U54GM104942
6 · The paper itself

Abstract

aims/hypothesisThe aim of this study was to determine the long-term associations of a sex- and race/ethnicity-specific metabolic syndrome (MetS) severity z score from childhood and adulthood with a future diagnosis of type 2 diabetes mellitus.

methodsWe performed a prospective cohort study with evaluations from the Cincinnati Clinic of the National Heart Lung and Blood Institute Lipids Research Clinic (LRC) 1973-1976 and Princeton Follow-up Study (PFS) 1998-2003, and further disease status from the Princeton Health Update (PHU) 2010-2014. We assessed MetS severity as a predictor of incident type 2 diabetes among 629 cohort participants assessed at both the LRC and PFS and 354 participants at the PHU.

resultsCohort participants had a mean age of 12.9 years at baseline (LRC), 38.4 years at the PFS and 49.6 years at the most recent follow-up. Childhood MetS z scores were associated with adult MetS z scores (p < 0.01). Compared with individuals who were disease-free at all time-points, those who developed type 2 diabetes by 1998-2003 and 2010-2014 had higher MetS severity z scores in childhood (p < 0.05). For every one-unit elevation in childhood MetS z score, the OR of developing future type 2 diabetes was 2.7 for incident disease by a mean age of 38.5 years (p < 0.01) and 2.8 for incident disease by a mean age of 49.6 years (p < 0.05). Regarding associations with the change in z score from childhood to adulthood, for every one-unit increase in MetS z score over time the OR of developing incident type 2 diabetes by a mean age of 49.6 years was 7.3 (p < 0.01). CONCLUSIONS/

interpretationThe severity of MetS in childhood was associated with the incidence of adult type 2 diabetes and the degree of increase in this severity predicted future disease. These findings provide evidence of potential clinical utility in assessing MetS severity to detect risk and follow clinical progress over time.

Indexed as

AdolescentAdultBody Mass IndexChildCohort StudiesDiabetes Mellitus, Type 2Disease ProgressionFemaleFollow-Up StudiesHumansLipidsMaleMetabolic SyndromeMiddle AgedPredictive Value of TestsProspective StudiesLipidsInsulin resistanceMetabolic syndromeRiskType 2 diabetes mellitus

Identifiers

PMID26380985
PMCPMC4734129
OpenAlexW1656265260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.